117 related articles for article (PubMed ID: 2572952)
1. The partial opiate receptor agonists, dezocine and ciramadol act as mu receptor antagonists at the feline ileocecal sphincter.
Ouyang A
Life Sci; 1989; 45(16):1491-7. PubMed ID: 2572952
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and respiratory effects of dezocine, ciramadol, and morphine.
Rothbard RL; Schreiner BF; Yu PN
Clin Pharmacol Ther; 1985 Jul; 38(1):84-8. PubMed ID: 3839174
[TBL] [Abstract][Full Text] [Related]
3. Characterization of opiate-mediated responses of the feline ileum and ileocecal sphincter.
Ouyang A; Clain CJ; Snape WJ; Cohen S
J Clin Invest; 1982 Mar; 69(3):507-15. PubMed ID: 6277992
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
Picker MJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
[TBL] [Abstract][Full Text] [Related]
5. Sites of action of mu-, kappa- and sigma-opiate receptor agonists at the feline ileocecal sphincter.
Ouyang A; Vos P; Cohen S
Am J Physiol; 1988 Feb; 254(2 Pt 1):G224-31. PubMed ID: 2894774
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the cardiorespiratory effects of ciramadol, dezocine, morphine and pentazocine in the anesthetized dog.
Lewis AJ; Kirchner T
Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):73-83. PubMed ID: 6115623
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436
[TBL] [Abstract][Full Text] [Related]
8. Anesthetic potency of dezocine and its interaction with morphine in rats.
Rowlingson JC; Moscicki JC; DiFazio CA
Anesth Analg; 1983 Oct; 62(10):899-902. PubMed ID: 6412596
[TBL] [Abstract][Full Text] [Related]
9. Assessment of dezocine for morphine-like subjective effects and miosis.
Jasinski DR; Preston KL
Clin Pharmacol Ther; 1985 Nov; 38(5):544-8. PubMed ID: 2865027
[TBL] [Abstract][Full Text] [Related]
10. Dezocine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
O'Brien JJ; Benfield P
Drugs; 1989 Aug; 38(2):226-48. PubMed ID: 2670517
[TBL] [Abstract][Full Text] [Related]
11. Ventilatory and analgesic effects of dezocine in humans.
Gal TJ; DiFazio CA
Anesthesiology; 1984 Dec; 61(6):716-22. PubMed ID: 6150661
[TBL] [Abstract][Full Text] [Related]
12. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
[TBL] [Abstract][Full Text] [Related]
14. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
Fischer BD; Miller LL; Henry FE; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 2008 Jun; 198(2):271-8. PubMed ID: 18392754
[TBL] [Abstract][Full Text] [Related]
15. Determination of ciramadol and dezocine, two new analgesics, by high-performance liquid chromatography using electrochemical detection.
Locniskar A; Greenblatt DJ
J Chromatogr; 1986 Jan; 374(1):215-20. PubMed ID: 3753984
[No Abstract] [Full Text] [Related]
16. Evidence for a direct and indirect action of leucine enkephalin at the feline ileocecal sphincter.
Bertiger G; Ouyang A; Reynolds JC; Cohen S
Life Sci; 1988; 42(18):1697-703. PubMed ID: 2896285
[TBL] [Abstract][Full Text] [Related]
17. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine.
Chen JC; Smith ER; Cahill M; Cohen R; Fishman JB
Life Sci; 1993; 52(4):389-96. PubMed ID: 8093631
[TBL] [Abstract][Full Text] [Related]
18. Opioid antagonist effects of dezocine in opioid-dependent humans.
Strain EC; Preston KL; Liebson IA; Bigelow GE
Clin Pharmacol Ther; 1996 Aug; 60(2):206-17. PubMed ID: 8823239
[TBL] [Abstract][Full Text] [Related]
19. Increased neuropeptide-converting enzyme activities in cerebrospinal fluid of opiate-tolerant rats.
Persson S; Post C; Alari L; Nyberg F; Terenius L
Neurosci Lett; 1989 Dec; 107(1-3):318-22. PubMed ID: 2482463
[TBL] [Abstract][Full Text] [Related]
20. Subjective, behavioral, and physiologic responses to intravenous dezocine in healthy volunteers.
Zacny JP; Lichtor JL; de Wit H
Anesth Analg; 1992 Apr; 74(4):523-30. PubMed ID: 1348168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
